De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Mindset Pharma Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Mindset Pharma's earnings have been declining at an average annual rate of -10.6%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 124.8% per year.
Belangrijke informatie
-10.6%
Groei van de winst
9.3%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 23.1% |
| Inkomstengroei | 124.8% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -78.8% |
| Laatste winstupdate | 31 Mar 2023 |
Recente prestatie-updates uit het verleden
Geen updates
Opbrengsten en kosten
Hoe Mindset Pharma geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 23 | 8 | -6 | 4 | 9 |
| 31 Dec 22 | 8 | -5 | 3 | 9 |
| 30 Sep 22 | 6 | -9 | 6 | 7 |
| 30 Jun 22 | 4 | -17 | 10 | 7 |
| 31 Mar 22 | 2 | -21 | 12 | 7 |
| 31 Dec 21 | 0 | -21 | 12 | 6 |
| 30 Sep 21 | 0 | -16 | 10 | 4 |
| 30 Jun 21 | 0 | -12 | 4 | 2 |
| 31 Mar 21 | 0 | -7 | 2 | 1 |
Kwaliteitswinsten: MSET is currently unprofitable.
Groeiende winstmarge: MSET is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if MSET's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Unable to compare MSET's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: MSET is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).
Rendement op eigen vermogen
Hoge ROE: MSET's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.